Alimera Sciences Inc (ALIM)
3.63
+0.04
(+1.11%)
USD |
NASDAQ |
Apr 24, 16:00
3.60
-0.03
(-0.83%)
After-Hours: 20:00
Alimera Sciences Debt to Equity Ratio: 1.397 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.397 |
| September 30, 2023 | 1.315 |
| June 30, 2023 | 1.383 |
| March 31, 2023 | -2.334 |
| December 31, 2022 | -2.114 |
| September 30, 2022 | -2.423 |
| June 30, 2022 | -3.527 |
| March 31, 2022 | -5.039 |
| December 31, 2021 | -16.54 |
| September 30, 2021 | 28.52 |
| June 30, 2021 | 7.230 |
| March 31, 2021 | -3.690 |
| December 31, 2020 | -5.501 |
| September 30, 2020 | -5.718 |
| June 30, 2020 | -5.764 |
| March 31, 2020 | -7.660 |
| December 31, 2019 | -8.697 |
| September 30, 2019 | -5.945 |
| June 30, 2019 | -10.40 |
| March 31, 2019 | 58.95 |
| December 31, 2018 | 13.91 |
| September 30, 2018 | 12.68 |
| Date | Value |
|---|---|
| June 30, 2018 | 6.764 |
| March 31, 2018 | 4.357 |
| December 31, 2017 | 2.303 |
| September 30, 2017 | 1.638 |
| June 30, 2017 | 1.552 |
| March 31, 2017 | 1.665 |
| December 31, 2016 | 1.293 |
| September 30, 2016 | 1.113 |
| June 30, 2016 | 2.864 |
| March 31, 2016 | 1.991 |
| December 31, 2015 | 1.208 |
| September 30, 2015 | 1.033 |
| June 30, 2015 | 0.8007 |
| March 31, 2015 | 0.8449 |
| December 31, 2014 | 0.6732 |
| September 30, 2014 | 4.127 |
| June 30, 2014 | 0.6818 |
| March 31, 2014 | 0.4173 |
| December 31, 2013 | -0.987 |
| September 30, 2013 | 0.5436 |
| June 30, 2013 | 0.5015 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-16.54
Minimum
Dec 2021
28.52
Maximum
Sep 2021
-2.395
Average
-3.690
Median
Mar 2021
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.342 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 153.52M |
| Total Liabilities (Quarterly) | 107.35M |
| Shareholders Equity (Quarterly) | 46.17M |
| Current Ratio | 2.392 |
| Net Debt Paydown Yield | -1.83% |